|
C2ORF29 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.5475000000027E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.61160000000149E-05 |
| Normal-vs-Stage2 |
4.922000E-02 |
| Normal-vs-Stage3 |
3.836700E-03 |
| Normal-vs-Stage4 |
2.083000E-03 |
| Stage1-vs-Stage2 |
4.371400E-01 |
| Stage1-vs-Stage3 |
8.192600E-01 |
| Stage1-vs-Stage4 |
9.556200E-01 |
| Stage2-vs-Stage3 |
6.504000E-01 |
| Stage2-vs-Stage4 |
5.002400E-01 |
| Stage3-vs-Stage4 |
8.261800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.64179999999825E-05 |
| Normal-vs-AfricanAmerican |
1.203770E-01 |
| Normal-vs-Asian |
4.428800E-01 |
| Caucasian-vs-AfricanAmerican |
3.561500E-02 |
| Caucasian-vs-Asian |
5.485000E-01 |
| AfricanAmerican-vs-Asian |
9.868800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.380300E-04 |
| Normal-vs-Female |
1.62515999999613E-05 |
| Male-vs-Female |
8.315800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.190200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.403800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.41119999999851E-05 |
| Normal-vs-Age(81-100Yrs) |
8.412400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.543230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.170300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.142800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.566800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.782600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.104200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.562200E-02 |
| Normal-vs-Grade 2 |
2.99569999995253E-06 |
| Normal-vs-Grade 3 |
6.810100E-04 |
| Normal-vs-Grade 4 |
7.664500E-02 |
| Grade 1-vs-Grade 2 |
4.653600E-01 |
| Grade 1-vs-Grade 3 |
9.406800E-01 |
| Grade 1-vs-Grade 4 |
5.478600E-01 |
| Grade 2-vs-Grade 3 |
1.039980E-01 |
| Grade 2-vs-Grade 4 |
2.220100E-02 |
| Grade 3-vs-Grade 4 |
2.789200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.51990000030189E-07 |
| Normal-vs-ccB subtype |
2.436200E-02 |
| ccA subtype-vs-ccB subtype |
7.355900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.002830E-04 |
| Normal-vs-N1 |
8.974400E-02 |
| N0-vs-N1 |
7.386000E-01 |
|
|
